GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BBS-Bioactive Bone Substitutes PLC (OHEL:BONEH) » Definitions » Change In Receivables

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Change In Receivables : €0.01 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is BBS-Bioactive Bone Substitutes Change In Receivables?

BBS-Bioactive Bone Substitutes's change in receivables for the quarter that ended in Dec. 2023 was €-0.05 Mil. It means BBS-Bioactive Bone Substitutes's Accounts Receivable increased by €0.05 Mil from Jun. 2023 to Dec. 2023 .

BBS-Bioactive Bone Substitutes's change in receivables for the fiscal year that ended in Dec. 2023 was €0.01 Mil. It means BBS-Bioactive Bone Substitutes's Accounts Receivable declined by €0.01 Mil from Dec. 2022 to Dec. 2023 .

BBS-Bioactive Bone Substitutes's Accounts Receivable for the quarter that ended in Dec. 2023 was €0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. BBS-Bioactive Bone Substitutes's liquidation value for the six months ended in Dec. 2023 was €-3.53 Mil.


BBS-Bioactive Bone Substitutes Change In Receivables Historical Data

The historical data trend for BBS-Bioactive Bone Substitutes's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BBS-Bioactive Bone Substitutes Change In Receivables Chart

BBS-Bioactive Bone Substitutes Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only 0.02 0.17 0.08 0.08 0.01

BBS-Bioactive Bone Substitutes Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.10 -0.01 0.06 -0.05

BBS-Bioactive Bone Substitutes Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BBS-Bioactive Bone Substitutes  (OHEL:BONEH) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

BBS-Bioactive Bone Substitutes's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

2. In Ben Graham's calculation of liquidation value, BBS-Bioactive Bone Substitutes's accounts receivable are only considered to be worth 75% of book value:

BBS-Bioactive Bone Substitutes's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1.971-5.505+0.75 * 0+0.5 * 0
=-3.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BBS-Bioactive Bone Substitutes Change In Receivables Related Terms

Thank you for viewing the detailed overview of BBS-Bioactive Bone Substitutes's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


BBS-Bioactive Bone Substitutes (OHEL:BONEH) Business Description

Traded in Other Exchanges
N/A
Address
Kiviharjunlenkki 6, Oulu, FIN, 90220
BBS-Bioactive Bone Substitutes PLC is a health technology company, that develops, designs, and manufactures bioactive bone-graft substitute implants. Its ortho-biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Headlines

No Headlines